Publication: 3845

Publication: 3845

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 41 (18) 3352-3362

Year:: 2023
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes
Book Volume:: 12

Parents:: 3071
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Astellas
Grants:: U10CA180821, U10CA180882, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233323, UG1CA233339, P30 CA008748, U10CA180888, UG1CA180830 (SWOG); P30 CA047904, R50 CA211241;UG1 CA233184, U10 CA180863

Corr. Author:
Authors:: Michael J. Morris Glenn Heller David W. Hillman Olivia Bobek Charles Ryan Emmanuel S. Antonarakis Alan H. Bryce Olwen Hahn Himisha Beltran Andrew J. Armstrong Lawrence Schwartz Lionel D. Lewis Jan H. Beumer Brooke Langevin Eric C. McGary Paul T. Mehan Amir Goldkorn Bruce J. Roth Han Xiao Colleen Watt Mary-Ellen Taplin Susan Halabi Eric J. Small

Networks:: CA011, CA824, HEARTLAND, KAISER, LAPS-IL057, LAPS-MA036, LAPS-MD017, LAPS-MO011, LAPS-NC010, LAPS-NH012, LAPS-NY016, MN022

Study: Alliance-A031201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: ORIGINAL REPORTS, Genitourinary Cancer